Skip to main content

Teva stock jumps after company reaches tentative $4.25B opioid litigation settlement deal

Teva acquired two branded opioid products when it bought Chester County-based Cephalon in 2011.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.